NCT03413371
- Conditions
- Nausea, Neurologic Manifestations, Oculocardiac Reflex, +11 more
- Locations
-
- Medical University of Silesia Sosnowiec, Silesian Voivodeship, Poland
Clinical trial condition
Signs and Symptoms, Digestive
Explore clinical trials studying Signs and Symptoms, Digestive. Study availability and eligibility vary by location and protocol.
3,786 public trials
399 recruiting studies
Signs and Symptoms, Digestive trial results
NCT07600970
- Conditions
- Eating Disorders, Eating Disorders Symptoms, Feeding and Eating Disorders, +4 more
- Locations
-
- San Francisco State University San Francisco, California, United States
NCT01655771
- Conditions
- Chemically-Induced Disorders, Constipation, Mental Disorders, +6 more
- Locations
-
- ICON Development Solutions San Antonio, Texas, United States
NCT07604818
- Conditions
- Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Craniofacial Abnormalities, +22 more
- Locations
-
- Hôpital Croix Rousse Lyon, Rhone, France
NCT07604857
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer (GC), +11 more
- Locations
-
- Seoul St. Mary's Hospital Seoul, South Korea
NCT01333540
- Conditions
- Chemically-Induced Disorders, Constipation, Mental Disorders, +7 more
- Locations
-
- Clinical Research Unit Salt Lake City, Utah, United States
NCT01459926
- Conditions
- Chemically-Induced Disorders, Constipation, Mental Disorders, +7 more
- Locations
-
- G and L Research, LLC Foley, Alabama, United States
Completed
A Multiple Dose Study of TD-1211 in Healthy Volunteers and Patients With Opioid-Induced Constipation
NCT01040637
- Conditions
- Chemically-Induced Disorders, Constipation, Healthy, +8 more
- Locations
-
- Clinical Research Unit Pasadena, California, United States
- Clinical Research Unit San Antonio, Texas, United States
- Clinical Research Unit Salt Lake City, Utah, United States
NCT01401985
- Conditions
- Chemically-Induced Disorders, Constipation, Mental Disorders, +7 more
- Locations
-
- Theravance Biopharma Investigational Site Pasadena, California, United States
NCT06556277
- Conditions
- Body Weight, Glucocorticoids, Hyperphagia, +10 more
- Locations
-
- University Hospital Basel Basel, Canton of Basel-City, Switzerland